Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions
Abbas Jarrahi1, Molly Braun1,2,3, Meenakshi Ahluwalia4
1Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Abstract:
Studying the complex molecular mechanisms involved in traumatic brain injury (TBI) is crucial for developing new therapies for TBI. Current treatments for TBI are primarily focused on patient stabilization and symptom mitigation. However, the field lacks defined therapies to prevent cell death, oxidative stress, and inflammatory cascades which lead to chronic pathology. Little can be done to treat the mechanical damage that occurs during the primary insult of a TBI; however, secondary injury mechanisms, such as inflammation, blood-brain barrier (BBB) breakdown, edema formation, excitotoxicity, oxidative stress, and cell death, can be targeted by therapeutic interventions. Elucidating the many mechanisms underlying secondary injury and studying targets of neuroprotective therapeutic agents is critical for developing new treatments. Therefore, we present a review on the molecular events following TBI from inflammation to programmed cell death and discuss current research and the latest therapeutic strategies to help understand TBI-mediated secondary injury.
Insights
Traumatic brain injury (TBI) research needs better therapies targeting secondary injury mechanisms like inflammation and cell death. This review explores molecular events and therapeutic strategies for TBI secondary injury.
Area of Science:
- Neuroscience
- Molecular Biology
- Trauma Surgery
Background:
- Current traumatic brain injury (TBI) treatments focus on stabilization, lacking therapies for secondary injury.
- Secondary injury mechanisms include inflammation, oxidative stress, and cell death, contributing to chronic pathology.
- Targeting these secondary events is crucial for developing effective TBI interventions.
Purpose of the Study:
- To review the molecular mechanisms of secondary injury following TBI.
- To discuss current research and therapeutic strategies for TBI.
- To elucidate targets for neuroprotective agents in TBI treatment.
Main Methods:
- Literature review of molecular events post-TBI.
- Analysis of secondary injury pathways (inflammation, oxidative stress, cell death).
- Evaluation of current and emerging therapeutic strategies.
Main Results:
- Detailed examination of inflammatory and programmed cell death pathways post-TBI.
- Identification of key molecular targets within secondary injury cascades.
- Overview of neuroprotective agents and their mechanisms.
Conclusions:
- Understanding TBI's molecular sequelae is vital for therapeutic development.
- Targeting secondary injury mechanisms offers promising avenues for TBI treatment.
- Further research into neuroprotection is critical for improving TBI outcomes.
